Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPartners Grp E Regulatory News (PEY)

Share Price Information for Partners Grp E (PEY)

Share Price is delayed by 15 minutes
Get Live Data
8.40    -0.08 (-0.94%)
Bid:
8.36
Ask:
8.44
Spread: 0.08 (0.957%)
Market Cap: €568.75m
PEY Live PriceLast checked at - London Stock Exchange

Intraday Partners Grp E Share Chart

Princess September NAV / quarterly call tomorrow

25 Oct 2012 17:51

RNS Number : 5881P
Princess Private Equity Holding Ltd
25 October 2012
 



News Release

 

Guernsey, 25 October 2012

 

Princess declares September NAV / quarterly call tomorrow

 

The net asset value (NAV) of Princess Private Equity Holding Limited (Princess, or the Company) fell by 0.4% in September to end the month at EUR 8.81 per share. Valuation developments (+0.7%) had a positive impact on NAV during September, as the mature portfolio continued to generate successful realizations and value creation efforts continued to engender operational improvements in underlying portfolio companies. However, these positives were more than offset during the month by negative currency effects (-0.8%) stemming from the euro's strong appreciation against the US dollar. Year-to-date the Company's NAV growth stands at 2.7%.

 

In September, strong distribution proceeds (+EUR 15.2 million) from realized portfolio companies such as Gasmedi, NoteMachine and Bartec, again exceeded outgoings from new investments (-EUR 2.7 million). Gasmedi, a provider of medical gases to the healthcare sector, was sold to Air Liquide for an enterprise value of more than EUR 330 million, representing a 2.4x return on costs. Year-to-date, the Company's mature portfolio has now generated exit proceeds of EUR 118 million, which represents 103% of the total distributions received in 2011.

 

Princess also received further capital injections in late September (EUR 32.9 million), and early October (EUR 10.7 million), as part of the first installment payable to the Company following the transfer of 15 of the 17 buyout funds sold on the secondary market last month. Princess is expected to receive further cash proceeds in late December when the two remaining funds from the secondary sale are due to be transferred to the buyer.

 

To accelerate the portfolio's transition towards direct investments, Princess allocated USD 50 million from the recent secondary sale to the Partners Group Direct Mezzanine 2011 program, of which around half has already been drawn down in October. This allocation gives Princess access to a portfolio of direct mezzanine investments globally, including BSN medical, the producer and distributor of medical consumables. Princess will also allocate a further EUR 50 million to the Partners Group Direct Investments 2012 program.

 

Princess will hold a conference call on 26 October 2012, at 10.00am BST to update interested parties on the recent developments of the Princess portfolio. The information announced will refer to unaudited figures as of 30 September 2012.

 

 

 

Date: Friday, 26 October 2012

Time: 10:00am-11:00am (Dublin, London)

11:00am-12:00pm (Zurich, Frankfurt)

 

Phone number: +44 (0) 203 059 58 62 (from the UK)

+41 (0) 91 610 56 00 (from Continental Europe)

+1 (1) 866 291 41 66 (from the US)

 

All lines will be open ten minutes prior to the beginning of the conference call.

 

The results presentation will be available at http://www.princess-privateequity.net/en/investor_relations/web_cast_live-events.php?ml ahead of the conference call.

 

Further information is available in the monthly report which can be accessed via:

http://www.princess-privateequity.net/financialreports

 

Ends.

 

 

About Princess

 

Princess is an investment holding company founded in 1999 and domiciled in Guernsey. It invests, inter alia, in private equity and private debt investments. Princess is advised in its investment activities by Partners Group AG, a global private markets investment management firm with over EUR 25 billion in investment programs under management in private equity, private debt, private real estate and private infrastructure. Princess aims to provide shareholders with long-term capital growth and an attractive dividend yield. Princess is traded on the Frankfurt Stock Exchange (ticker symbol: PEY1) and on the London Stock Exchange (ticker symbol: PEY). Further information: www.princess-privateequity.net

 

Contacts

 

Princess Private Equity Holding Limited:

princess@princess-privateequity.net

www.princess-privateequity.net

 

Registered Number: 35241

 

Investor relations contact

Jan-Frederik Modell

Phone: +44 (0)20 7575 2753

E-mail: jan-frederik.modell@partnersgroup.com

 

Media relations contact

Partners Group AG

Dr. Anna Hollmann

Phone: +41 41 784 63 72

E-mail: anna.hollmann@partnersgroup.com

www.partnersgroup.com

 

This document does not constitute an offer to sell or a solicitation of an offer to buy or subscribe for any securities and neither is it intended to be an investment advertisement or sales instrument of Princess Private Equity Holding Limited. The distribution of this document may be restricted by law in certain jurisdictions. Persons into whose possession this document comes must inform themselves about, and observe any such restrictions on the distribution of this document. In particular, this document and the information contained therein is not for distribution or publication, neither directly nor indirectly, in or into the United States of America, Canada, Australia or Japan.

 

This document may have been prepared using financial information contained in the books and records of the product described herein as of the reporting date. This information is believed to be accurate but has not been audited by any third party. This document may describe past performance, which may not be indicative of future results. No liability is accepted for any actions taken on the basis of the information provided in this document. Neither the contents of Princess' website nor the contents of any website accessible from hyperlinks on Princess' website (or any other website) is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRPGGUAUUPPGQA
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSPGPE Ltd results presentation webcast details
18th May 20267:00 amRNSSave the date for Q1 2026 results announcement
7th May 20267:00 amRNSPGPE Ltd publishes March NAV
5th May 20267:00 amRNSDividend Declaration
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSNotice of Annual General Meeting
14th Apr 20267:00 amRNSPGPE Ltd publishes February NAV
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSBuyback update
7th Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSAnnual results and webcast details
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
16th Mar 20267:00 amRNSPGPE Ltd publishes January NAV
16th Mar 20267:00 amRNSSave the date for 2025 annual results announcement
25th Feb 20267:00 amRNSTransaction in Own Shares
16th Feb 20267:00 amRNSPGPE Ltd publishes December NAV
12th Feb 20264:51 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20267:00 amRNSTransaction in Own Shares
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:01 amRNSBuyback update
28th Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
14th Jan 20267:00 amRNSFree Cash Flow as at 31 December 2025
8th Jan 20267:04 amRNSPGPE Ltd publishes November NAV
24th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20257:00 amRNSNAV increased by 0.5% in October
10th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
27th Nov 20257:05 amRNSSale of Convex Group
27th Nov 20257:00 amRNSEsentia lists on Mexican Stock Exchange
26th Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSResults presentation webcast details
20th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20257:00 amRNSCredit facility renewed early
12th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSDividend Declaration
4th Nov 20257:00 amRNSNAV increased by 2.1% in September
4th Nov 20257:00 amRNSSave the date for Q3 2025 results announcement
3rd Nov 20257:00 amRNSSale of Clario

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.